Search Results - "HASHIGUCHI, Masayuki"

Estimating the range of incremental cost-effectiveness thresholds for healthcare based on willingness to pay and GDP per capita: A systematic review by Iino, Haru, Hashiguchi, Masayuki, Hori, Satoko

“…Decision-making in healthcare policy involves assessing both costs and benefits. In determining the cost-effectiveness (CE) threshold, willingness to pay (WTP)…”
Get full text

Meta-Analysis: Effects of Probiotic Supplementation on Lipid Profiles in Normal to Mildly Hypercholesterolemic Individuals by Shimizu, Mikiko, Hashiguchi, Masayuki, Shiga, Tsuyoshi, Tamura, Hiro-omi, Mochizuki, Mayumi

“…Recent experimental and clinical studies have suggested that probiotic supplementation has beneficial effects on serum lipid profiles. However, there are…”
Get full text

Meta-analysis comparing direct oral anticoagulants versus vitamin K antagonists in patients with left ventricular thrombus by Kido, Kazuhiko, Ghaffar, Yasir Abdul, Lee, James C, Bianco, Christopher, Shimizu, Mikiko, Shiga, Tsuyoshi, Hashiguchi, Masayuki

“…Current American College of Cardiology/American Heart Association guidelines for stroke or ST-elevation myocardial infarction recommend the use of oral vitamin…”
Get full text

Detection of Vaccine Adverse Events Before Package Insert Revisions Using a Japanese Spontaneous Reporting System by Suzuki, Shimon, Imai, Shungo, Mitsuboshi, Satoru, Kizaki, Hayato, Hashiguchi, Masayuki, Hori, Satoko

“…The usefulness of disproportionality analysis for the pharmacovigilance of vaccines in the Japanese Adverse Drug Event Report (JADER) database is yet to be…”
Get full text

Ocular findings in Japanese patients with hydroxychloroquine retinopathy developing within 3 years of treatment by Ozawa, Hiroko, Ueno, Shinji, Ohno-Tanaka, Akiko, Sakai, Takao, Hashiguchi, Masayuki, Shimizu, Mikiko, Fujinami, Kaoru, Ahn, Seong Joon, Kondo, Mineo, Browning, David J., Shinoda, Kei, Yokogawa, Naoto

“…Purpose To describe the characteristics of Japanese patients with hydroxychloroquine (HCQ) retinopathy developing within 3 years of treatment outset. Study…”
Get full text

Psychotherapeutic drug‐induced life‐threatening arrhythmias: A retrospective analysis using the Japanese adverse drug event report database by Yokohara, Saki, Hashiguchi, Masayuki, Shiga, Tsuyoshi

“…Background Drug‐induced life‐threatening ventricular arrhythmias including torsade de pointes (TdP), ventricular tachycardia (VT), and ventricular fibrillation…”
Get full text

Risk factors for severe neutropenia in pancreatic cancer patients treated with gemcitabine/nab-paclitaxel combination therapy by Ito, Genta, Kawakami, Kazuyoshi, Aoyama, Takeshi, Yokokawa, Takashi, Nakamura, Masashi, Ozaka, Masato, Sasahira, Naoki, Hashiguchi, Masayuki, Kizaki, Hayato, Hama, Toshihiro, Hori, Satoko

“…Combination therapy with gemcitabine and nanoparticle albumin-bound paclitaxel (nab-paclitaxel), known as GnP therapy, significantly prolongs the survival of…”
Get full text

Early‐Onset Hydroxychloroquine Retinopathy and a Possible Relationship to Blood Levels: Comment on the Article by Petri et al by Yokogawa, Naoto, Ohno‐Tanaka, Akiko, Hashiguchi, Masayuki, Shimizu, Mikiko, Ozawa, Hiroko, Ueno, Shinji, Shinoda, Kei, Browning, David J.

Get full text

Factors Predicting the Therapeutic Response to Methotrexate in Japanese Patients with Rheumatoid Arthritis: A Hospital-Based Cohort Study by Hakamata, Jun, Kaneko, Yuko, Shimizu, Mikiko, Yamaoka, Kunihiro, Maruyama, Junya, Takeuchi, Tsutomu, Mochizuki, Mayumi, Hashiguchi, Masayuki

“…Methotrexate (MTX) is used widely as a first-line drug for the treatment of rheumatoid arthritis (RA) worldwide. There are large interindividual differences in…”
Get full text

Factors predicting the therapeutic response to infliximab during maintenance therapy in Japanese patients with Crohn's disease by Matsuoka, Katsuyoshi, Hamada, Shunsuke, Shimizu, Mikiko, Nanki, Kosaku, Mizuno, Shinta, Kiyohara, Hiroki, Arai, Mari, Sugimoto, Shinya, Iwao, Yasushi, Ogata, Haruhiko, Hisamatsu, Tadakazu, Naganuma, Makoto, Kanai, Takanori, Mochizuki, Mayumi, Hashiguchi, Masayuki

“…Since anti-tumor necrosis factor (TNF)-α agents (TNF-α inhibitors) induce both clinical response and remission in patients with moderate to severe inflammatory…”
Get full text

Meta-analysis of the efficacy and safety of Ginkgo biloba extract for the treatment of dementia by Hashiguchi, Masayuki, Ohta, Yuriko, Shimizu, Mikiko, Maruyama, Junya, Mochizuki, Mayumi

“…The benefit of Ginkgo biloba for the treatment of dementia remains controversial. The aim of this study was to evaluate the efficacy and safety of Ginkgo…”
Get full text

Effect of common comparators in indirect comparison analysis of the effectiveness of different inhaled corticosteroids in the treatment of asthma by Kunitomi, Taro, Hashiguchi, Masayuki, Mochizuki, Mayumi

“…Indirect comparison (IC) and direct comparison (DC) of four inhaled corticosteroid (CS) treatments for asthma were conducted, and the factors that may…”
Get full text

Factors Affecting the Timing of Signal Detection of Adverse Drug Reactions by Hashiguchi, Masayuki, Imai, Shungo, Uehara, Keiko, Maruyama, Junya, Shimizu, Mikiko, Mochizuki, Mayumi

“…We investigated factors affecting the timing of signal detection by comparing variations in reporting time of known and unknown ADRs after initial drug release…”
Get full text

Indirect comparison analysis of efficacy and safety between olanzapine and aripiprazole for schizophrenia by Kunitomi, Taro, Hashiguchi, Masayuki, Mochizuki, Mayumi

“…Aims Indirect comparison (IC) and direct comparison (DC) between aripiprazole and olanzapine for schizophrenia were conducted to compare their efficacy and…”
Get full text

Risk factors for abnormal hepatic enzyme elevation by methotrexate treatment in patients with rheumatoid arthritis: A hospital based-cohort study by Hakamata, Jun, Hashiguchi, Masayuki, Kaneko, Yuko, Yamaoka, Kunihiro, Shimizu, Mikiko, Maruyama, Junya, Takeuchi, Tsutomu, Mochizuki, Mayumi

“…Objectives: Methotrexate (MTX) is used as first-line treatment of rheumatoid arthritis (RA) worldwide. Large interindividual differences in MTX effectiveness…”
Get full text

Effect of database profile variation on drug safety assessment: an analysis of spontaneous adverse event reports of Japanese cases by Nomura, Kaori, Takahashi, Kunihiko, Hinomura, Yasushi, Kawaguchi, Genta, Matsushita, Yasuyuki, Marui, Hiroko, Anzai, Tatsuhiko, Hashiguchi, Masayuki, Mochizuki, Mayumi

“…The use of a statistical approach to analyze cumulative adverse event (AE) reports has been encouraged by regulatory authorities. However, data variations…”
Get full text

Exploratory evaluation of a commercially available Japanese medical record database as an external control for comparative clinical trials in new drug development: Amyotrophic lateral sclerosis by Fukamachi, Saeko, Hashiguchi, Masayuki, Takahashi, Kunihiko, Mochizuki, Mayumi

“…Clinical trials with internal control groups may not always be feasible, especially for rare diseases. We performed an exploratory evaluation of the Medical…”
Get full text

Patients views and experiences in online reporting adverse drug reactions: findings of a national pilot study in Japan by Yamamoto, Michiko, Kubota, Kiyoshi, Okazaki, Mitsuhiro, Dobashi, Akira, Hashiguchi, Masayuki, Doi, Hirohisa, Suka, Machi, Mochizuki, Mayumi

“…Patients have been allowed to report adverse drug reactions (ADRs) directly to the government in some countries, which would contribute to pharmacovigilance…”
Get full text

Temporal relationship between multiple drugs and multiple events in patient reports on adverse drug reactions: findings in a pilot study in Japan by Kubota, Kiyoshi, Okazaki, Mitsuhiro, Dobashi, Akira, Yamamoto, Michiko, Hashiguchi, Masayuki, Horie, Arisa, Inagaki, Ataru, Kikuchi, Toshiaki, Mochizuki, Mayumi

Get full text

Genetic polymorphisms of enzyme proteins and transporters related to methotrexate response and pharmacokinetics in a Japanese population by Hashiguchi, Masayuki, Shimizu, Mikiko, Hakamata, Jun, Tsuru, Tomomi, Tanaka, Takanori, Suzaki, Midori, Miyawaki, Kumika, Chiyoda, Takeshi, Takeuchi, Osamu, Hiratsuka, Jiro, Irie, Shin, Maruyama, Junya, Mochizuki, Mayumi

“…Methotrexate (MTX) is currently the anchor drug widely used worldwide in the treatment of rheumatoid arthritis (RA). However, the therapeutic response to MTX…”
Get full text